• Refine Query
  • Source
  • Publication year
  • to
  • Language
  • 111
  • 34
  • 14
  • 14
  • 14
  • 14
  • 14
  • 14
  • 6
  • 5
  • 4
  • 2
  • 2
  • 1
  • 1
  • Tagged with
  • 210
  • 45
  • 27
  • 26
  • 24
  • 20
  • 20
  • 19
  • 18
  • 16
  • 16
  • 14
  • 14
  • 14
  • 13
  • About
  • The Global ETD Search service is a free service for researchers to find electronic theses and dissertations. This service is provided by the Networked Digital Library of Theses and Dissertations.
    Our metadata is collected from universities around the world. If you manage a university/consortium/country archive and want to be added, details can be found on the NDLTD website.
181

Immuno-oncology of human prostate cancer : phenotypical characterization and study of the tumor-derived, androgen-regulated immunosuppressive microenvironment

Gannon, Philippe 03 1900 (has links)
Le cancer de la prostate est le cancer le plus fréquemment diagnostiqué chez les hommes canadiens et la troisième cause de décès relié au cancer. Lorsque diagnostiqué à un stade précoce de la maladie, le cancer de la prostate est traité de manière curative par chirurgie et radiothérapie. Par contre, les thérapies actuelles ne peuvent éradiquer la maladie lorsqu’elle progresse à des stades avancés. Ces thérapies, comme la chimiothérapie et l’hormonothérapie, demeurent donc palliatives. Il est primordial d’optimiser de nouvelles thérapies visant l’élimination des cellules cancéreuses chez les patients atteints des stades avancés de la maladie. Une de ces nouvelles options thérapeutiques est l’immunothérapie. L’immunothérapie du cancer a fait des progrès considérables durant les dernières années. Cependant, les avancements encourageants obtenus lors d’essais précliniques ne se sont pas encore traduits en des résultats cliniques significatifs. En ce qui concerne le cancer de la prostate, les résultats négligeables suivants des interventions immunothérapeutiques peuvent être causés par le fait que la plupart des études sur le microenvironnement immunologique furent effectuées chez des modèles animaux. De plus la majorité des études sur l’immunologie tumorale humaine furent effectuées chez des patients atteints d’autres cancers, tels que le mélanome, et non chez les patients atteints du cancer de la prostate. Donc, le but central de cette thèse de doctorat est d’étudier le microenvironnement immunologique chez les patients atteints du cancer de la prostate afin de mieux définir les impacts de la tumeur sur le développement de la réponse immunitaire antitumorale. Pour réaliser ce projet, nous avons établi deux principaux objectifs de travail : (i) la caractérisation précise des populations des cellules immunitaires infiltrant la tumeur primaire et les ganglions métastatiques chez les patients atteints du cancer de la prostate; (ii) l’identification et l’étude des mécanismes immunosuppressifs exprimés par les cellules cancéreuses de la prostate. Les résultats présentés dans cette thèse démontrent que la progression du cancer de la prostate est associée au développement d’un microenvironnement immunosuppressif qui, en partie, est régulé par la présence des androgènes. L’étude initiale avait comme but la caractérisation du microenvironnement immunologique des ganglions drainant la tumeur chez des patients du cancer de la prostate. Les résultats présentés dans le chapitre III nous a permis de démontrer que les ganglions métastatiques comportent des signes cellulaires et histopathologiques associés à une faible réactivité immunologique. Cette immunosuppression ganglionnaire semble dépendre de la présence des cellules métastatiques puisque des différences immunologiques notables existent entre les ganglions non-métastatiques et métastatiques chez un même patient. La progression du cancer de la prostate semble donc associée au développement d’une immunosuppression affectant les ganglions drainant la tumeur primaire. Par la suite, nous nous sommes intéressés à l’impact de la thérapie par déplétion des androgènes (TDA) sur le microenvironnement immunologique de la tumeur primaire. La TDA est associée à une augmentation marquée de l’inflammation prostatique. De plus, les protocoles d’immunothérapies pour le cancer de la prostate actuellement évalués en phase clinique sont dirigés aux patients hormonoréfractaires ayant subi et échoué la thérapie. Cependant, peu d’information existe sur la nature de l’infiltrat de cellules immunes chez les patients castrés. Il est donc essentiel de connaître la nature de cet infiltrat afin de savoir si celui-ci peut répondre de manière favorable à une intervention immunothérapeutique. Dans le chapitre IV, je présente les résultats sur l’abondance des cellules immunes infiltrant la tumeur primaire suivant la TDA. Chez les patients castrés, les densités de lymphocytes T CD3+ et CD8+ ainsi que des macrophages CD68+ sont plus importantes que chez les patients contrôles. Nous avons également observé une corrélation entre la densité de cellules NK et une diminution du risque de progression de la maladie (rechute biochimique). Inversement, une forte infiltration de macrophages est associée à un plus haut risque de progression. Conjointement, durant cette étude, nous avons développé une nouvelle approche informatisée permettant la standardisation de la quantification de l’infiltrat de cellules immunes dans les échantillons pathologiques. Cette approche facilitera la comparaison d’études indépendantes sur la densité de l’infiltrat immun. Ces résultats nous ont donc permis de confirmer que les effets pro-inflammatoires de la TDA chez les patients du cancer de la prostate ciblaient spécifiquement les lymphocytes T et les macrophages. L’hypothèse intéressante découlant de cette étude est que les androgènes pourraient réguler l’expression de mécanismes immunosuppressifs dans la tumeur primaire. Dans le chapitre V, nous avons donc étudié l’expression de mécanismes immunosuppressifs par les cellules cancéreuses du cancer de la prostate ainsi que leur régulation par les androgènes. Notre analyse démontre que les androgènes augmentent l’expression de molécules à propriétés immunosuppressives telles que l’arginase I et l’arginase II. Cette surexpression dépend de l’activité du récepteur aux androgènes. Chez les patients castrés, l’expression de l’arginase II était diminuée suggérant une régulation androgénique in vivo. Nous avons observé que l’arginase I et l’arginase II participent à la prolifération des cellules du cancer de la prostate ainsi qu’à leur potentiel immunosuppressif. Finalement, nous avons découvert que l’expression de l’interleukin-8 était aussi régulée par les androgènes. De plus, l’interleukin-8, indépendamment des androgènes, augmente l’expression de l’arginase II. Ces résultats confirment que les androgènes participent au développement d’une microenvironnement immunosuppressif dans le cancer de la prostate en régulant l’expression de l’arginase I, l’arginase II et l’interleukin-8. En conclusion, les résultats présentés dans cette thèse témoignent du caractère unique du microenvironnement immunologique chez les patients atteints du cancer de la prostate. Nos travaux ont également permis d’établir de nouvelles techniques basées sur des logiciels d’analyse d’image afin de mieux comprendre le dialogue entre la tumeur et le système immunitaire chez les patients. Approfondir les connaissances sur les mécanismes de régulation du microenvironnement immunologique chez les patients atteint du cancer de la prostate permettra d’optimiser des immunothérapies mieux adaptées à éradiquer cette maladie. / Prostate cancer is the most frequently diagnosed cancer in Canadian men and the third cause of cancer related death. When diagnosed at an early stage, prostate cancer can be effectively cured by surgery and radiotherapy. However, current therapies do not eradicate the advanced stages of the disease. Treatment of prostate cancer via chemotherapy or hormonotherapy remains palliative. It is thus essential to optimize novel therapies whose goal is to eliminate tumor cells in patients with advanced prostate cancer. One such approach is immunotherapy. Cancer immunotherapy has made important strides in recent years. The encouraging progress observed in pre-clinical trials has nonetheless not translated to significant results in the clinical setting. Concerning prostate cancer, the limited clinical efficacy of current immunotherapeutic protocols could be explained by the lack of studies directly evaluating the immunological microenvironment in prostate cancer patients and not in animal models or in patients afflicted by other malignancies, such as melanoma. Thus, the fundamental goal of this Ph.D. thesis is to study the immunological microenvironment in prostate cancer patients in order to better understand the impact of the tumor on the development of the anti-tumoral immune response. To realize this project, we established two main working objectives: (i) to precisely characterize the immune cell populations in tumor draining lymph nodes (LNs) and in the primary tumor of prostate cancer patients; (ii) to identify and to study the immunosuppressive pathways expressed by prostate cancer cells. The results detailed in this thesis demonstrate that prostate cancer progression is associated with the development of an immunosuppressive microenvironment, which is regulated, in part, by the presence of androgens. The initial study was based on the characterization of the immunological microenvironment of tumor draining LNs of prostate cancer patients. The results presented in chapter III allowed us to demonstrate that metastatic lymph nodes displayed cellular and histopathological evidence associated with a reduced immunological reactivity. This LN immunosuppression seemed to be dependant on the presence of metastatic cells as we noted significant immunological differences between non-metastatic and metastatic lymph nodes of the same patient. Prostate cancer progression was thus associated with the development of an immunosuppressive state, which affected tumor-draining lymph nodes. Next, we studied the impact of androgen deprivation therapy (ADT) on the immunological microenvironment of the primary tumor. Following ADT, there is a marked augmentation in intra-prostatic inflammation. Immunotherapeutic protocols currently evaluated in clinical trials are targeted at hormone refractory patients, which have received and failed ADT. However, very little information is available regarding the nature of the post-ADT immune infiltrate. Thus, it becomes essential to understand whether this post-ADT infiltrate could positively react to immunotherapy. In chapter IV, I present the results of the quantification of the immune cell abundance within the primary tumor. In patients who have received ADT prior to surgery, there was an elevated density of CD3+ and CD8+ T lymphocytes as well as CD68+ macrophages compared to control patients. We also observed an inverse correlation between the NK cell density and the risk of disease progression (biochemical recurrence). Conversely, an elevated macrophage infiltration was associated with a higher risk of progression. Furthermore, for this study, we developed a novel computerized approach allowing for the standardization of the quantification of immune cell infiltrate. This approach could facilitate the interpretation of results from independent studies on the density of immune cells within pathological specimens. This study confirmed that the pro-inflammatory impact of androgen deprivation therapy in prostate cancer patients target specifically the T lymphocyte and macrophage populations. The interesting hypothesis arising from this study was that androgens could positively regulate the expression of immunosuppressive pathways within the primary tumor. In chapter V, we evaluated the immunosuppressive mechanisms expressed by prostate cancer cells and regulated by androgens. Our analysis demonstrate that androgens increase the expression of molecules with immunosuppressive properties, such as arginase I and arginase II in an androgen receptor dependent manner. This androgen regulated expression of arginase II was also observed in prostate cancer patients treated by ATD. We observed that arginase I and arginase II participate in prostate cancer cell proliferation as well as in their immunosuppressive potential. Finally, we discovered that interleukin-8 expression was also regulated by androgens. Moreover, interleukin-8, independently of androgens, increased the expression of arginase II. Altogether, these results confirmed that androgens participate in the development of an immunosuppressive microenvironment in prostate cancer by regulating the expression of arginase I, arginase II and interlukin-8. In conclusion, the results presented in this thesis attest to the unique character of the immunological microenvironment in prostate cancer patients. Our work has also allowed to establish novel software-based analysis methods in order to better understand the dialogue between the tumor and the immune system. Further understanding of the regulatory pathways involved in the immunological microenvironment will allow for the optimization of immunotherapies better suited to eradicate prostate cancer.
182

Studies on premenstrual dysphoria /

Eriksson, Olle, January 2005 (has links)
Diss. (sammanfattning) Uppsala : Uppsala universitet, 2005. / Härtill 4 uppsatser.
183

Novel transgenic medaka models to detect disruption of sex hormone signalling and gonadal development / Modèles de medaka transgéniques nouveaux pour détecter la perturbation dans la signalisation des hormones sexuelles et le développement gonadique

Spirhanzlova, Petra 04 October 2016 (has links)
La pression toxique induite par les perturbateurs endocriniens sur l’environnement ainsi que sur la santé de l’homme a augmenté de manière significative durant les dernières décennies. Il est devenu urgent de mettre en place des outils pour détecter et surveiller les perturbateurs endocriniens et pour déterminer la possibilité de cause de perturbations endocriniennes pour les produits chimiques nouvellement introduits. Le développement de nouveaux tests biologiques in vivo en utilisant les larves d'organismes aquatiques tels que medaka (Oryzias latipes) ou Xenopus laevis semble être une stratégie adéquate pour identifier les perturbateurs endocriniens. Durant cette thèse, trois nouveaux modèles transgéniques à base de l’embryon de medaka ont été développés. Le modèle transgénique de medaka ChgH -gfp permet la détection rapide des œstrogènes et des inhibiteurs de l'aromatase en seulement 24 heures avec une sensibilité de 15 ng / L d’éthinylestradiol. Le modèle transgénique de medaka 42sp50-gfp_CgH-gfp montre une fluorescence dans le foie en réponse aux œstrogènes, en plus de la fluorescence émise dans les œufs en développement. C’est donc un système approprié pour étudier le lien entre la signalisation de l'axe ostrogénique et des aberrations de la détermination du sexe chez les poissons. Un embryon transgénique de medaka spiggin - GFP a aussi été développé pour détecter les androgènes et anti-androgènes dans un test de 96 heures avec une sensibilité de 1,5 ug / L de 17α–méthyl testostérone et 276 ug / L de flutamide. Les nouveaux modèles de medaka transgéniques rapporteurs développés dans cette thèse permettent une détection rapide, simple et fiable des perturbateurs d'axe ostrogénique, androgénique et de l’aberration de détermination du sexe chez le medaka. Ils ont été appliqués pour détecter les perturbateurs endocriniens dans les eaux de surface de l'environnement et pour évaluer le rôle potentiel des produits chimiques dans les perturbations endocriniennes. Cela a permis de démontrer l’applicabilité de ces embryons fluorescents comme outils biologiques dans la procédure de détection et la caractérisation des perturbateurs endocriniens. / The toxic pressure of endocrine disruptors on biodiversity and human health has increased significantly over recent decades. As a consequence tools are needed to detect and monitor endocrine disruptors in surface water and to determine the endocrine disrupting potential of newly introduced chemicals. Fish and amphibian larvae, notably the medaka (Oryzias latipes) and Xenopus laevis, offer multiple advantages in this context. In the research carried out in the context of this thesis, different novel medaka-based transgenic models were developed. First, transgenic ChgH-gfp medaka model was designed and optimized for the rapid detection of estrogens and aromatase inhibitors. The model shows significant response within 24 hours with a sensitivity of 15 ng/L ethinylestradiol. Second, a double transgenic 42sp50-gfp_ChgH-gfp medaka which exhibits fluorescence both in the liver in response to estrogens and in developing oocytes as a function of phenotypic sex. It is therefore a suitable model for studying the link between estrogen axis signalling and aberrations of sex determination in fish. Third, a novel spiggin-gfp medaka model was developed to detect androgens and anti-androgens. This model can be exploited in a 96-hour assay with a sensitivity of 1.5 μg/L 17α- methyltestosterone and 276 μg/L flutamide. The novel transgenic medaka models developed in this thesis allow rapid, simple and reliable detection of estrogen and androgen axis disruption and aberrations in medaka sex determination. They have been successfully applied to detect endocrine disruptors in environmental surface water and to assess chemicals with unknown endocrine disrupting potential. Taken together these results demonstrate the applicability of medaka reporter larvae as biological tools in the procedure of detection and characterization of endocrine disruptors.
184

Marcadores de risco cardiometabólico, atividade física habitual e androgênios em mulheres com a síndrome dos ovários policísticos

Neves, Fernanda Misso Mario das January 2016 (has links)
Síndrome dos Ovários Policísticos (PCOS), caracterizada por disfunção ovulatória e hiperandrogenismo, é a endocrinopatia mais frequente entre mulheres em idade reprodutiva, afetando aproximadamente de 6 a 19% desta população, conforme o critério diagnóstico empregado. Além dos distúrbios reprodutivos, as mulheres com PCOS frequentemente apresentam maior prevalência de fatores de risco cardiometabólico como obesidade abdominal, dislipidemia, hipertensão, tolerância diminuída à glicose e diabetes mellitus tipo 2. A resistência insulínica e a hiperinsulinemia compensatória são consideradas como o ponto central destas alterações metabólicas. Os critérios atuais para diagnóstico de PCOS, a partir do Consenso de Rotterdam, indroduziram diferentes fenótipos. Os mais frequentes são o fenótipo “clássico” (hiperandrogenismo e anovulução, com ou sem a aparência policística do ovário), e o fenótipo “ovulatório” (hiperandrogenismo e aparência policística do ovário). Evidências sugerem que as mulheres com PCOS fenótipo “clássico” tenham alterações metabólicas mais severas comparadas às mulheres com o fenótipo ovulatório. Em razão disto, o objetivo do primeiro artigo original foi avaliar o desempenho da circunferência abdominal, da razão cintura-estatura, do índice de conicidade, do produto da acumulação lipídica (LAP) e do índice de adiposidade visceral (VAI) com base no modelo de homeostasia de à insulina (HOMA-IR)≥ 3,8 como padrão de referência para rastreamento de alterações Este estudo mostrou que, dentre os índices de adiposidade avaliados, os que apresentaram maior acurácia foram o LAP entre as mulheres com PCOS fenótipo “clássico” e o VAI entre as com fenótipo “ovulatório”. Aplicando o ponto de corte do LAP< 34, identificamos um subgrupo de pacientes sem alterações cardiometabólicas no grupo de mulheres com PCOS com fenótipo “clássico”, população com maior risco de hipertensão, de dislipidemia e de tolerância diminuída à glicose. Dentre as mulheres com PCOS classificadas com o fenótipo “ovulatório”, VAI≥ 1,32 foi capaz de detectar mulheres com pressão arterial significativamente mais alta e variáveis glicêmicas e lipídicas menos favoráveis em relação às mulheres com PCOS com fenótipo “ovulatório” com VAI abaixo deste ponto de corte. Atualmente, mudanças de estilo de vida (dieta e/ou exercício físico) são consideradas como primeira opção de tratamento não farmacológico nas mulheres com PCOS. Embora a prática de, pelo menos, 30 minutos por dia de exercício físico estruturado seja recomendada e tenha mostrado um potencial efeito na melhora da resistência insulínica e das variáveis antropométricas e hormonais, a manutenção deste hábito a longo prazo permanece como um ponto crítico. Neste sentido, o objetivo do segundo artigo foi avaliar o efeito da atividade física habitual (AFH) nos perfis metabólico e hormonal de mulheres com PCOS e controles pareadas por idade e índice de massa corporal (IMC). A AFH das participantes foi avaliada por meio de pedômetro digital e, conforme o número de passos diário, a participante foi classificada como ativa (≥ 7500 passos/dia) ou sedentária (< 7500 passos/dia). Mulheres ativas, em ambos os diagnósticos, apresentaram menor IMC, circunferência abdominal e LAP. No grupo PCOS, as mulheres ativas apresentaram menores valores de testosterona total, androstenediona e índice de androgênios livres (IAL) em comparação às sedentárias. Além disto, o aumento de 2000 passos foi um preditor independente de redução do IAL nas mulheres com a síndrome. Este estudo mostrou que ser mais ativa foi associado a um perfil antropométrico e metabólico mais saudável, portanto encorajar um estilo de vida mais ativo pode ser benéfico para mulheres com PCOS, especialmente para as obesas e sedentárias. / Polycystic Ovary Syndrome (PCOS) is characterized by ovulatory dysfunction a hyperandrogenism. The prevalence of PCOS in women of reproductive age range from 6- 19%. Women with PCOS present higher prevalence of cardiometabolic risk factors as abdominal obesity, dyslipidemia, hypertension, impaired glucose tolerance and diabetes mellitus type 2. These metabolic abnormalities have been primarily linked to insulin resistance. Currently, the diagnosis of PCOS is confirmed according the Rotterdam Consensus. The more frequent phenotypes are the classic phenotype (hyperandrogenism and anovulation with or without polycystic ovary appearance), and the ovulatory phenotype (hyperandrogenism and polycystic ovary appearance). Evidence suggests that women with classic PCOS phenotype present more severe metabolic alterations compared to women with ovulatory PCOS phenotype. The aim of the first study was to evaluate the performance of the waist circumference (WC), waist-to-height ratio, conicity index, lipid accumulation product (LAP), and visceral adiposity index (VAI) based on homeostasis model assessment of insulin resistance (HOMA- IR)≥ 3.8 as standard reference for screening preclinical metabolic alterations and cardiovascular risk factors in classic PCOS and ovulatory PCOS phenotypes. Among these indexes, LAP had the best accuracy for screening metabolic alterations in classic PCOS phenotype, while VAI had the best accuracy for ovulatory PCOS phenotype. cardiometabolic alterations in the group with classic PCOS, a phenotype which is characterized by higher risk for hypertension, dyslipidemia, and impaired glucose tolerance. In ovulatory PCOS, VAI≥ 1.32 was useful to detect women with significantly higher blood pressure and less favorable glycemic and lipid variables as compared to ovulatory PCOS with lower VAI. In addition, lifestyle intervention (diet and/or exercise) is the first-line treatment for PCOS. Although structured exercise (at least 30 minutes daily) has been recommended and has shown a potential effect on improving insulin resistance, anthropometric, and hormonal variables, the long-term maintenance of exercise remains a critical point. Therefore, the aim of the second study was to objectively examine the effect of habitual PA on metabolic, hormonal, BMI, and anthropometric variables of women with PCOS and a control group, matched by age and BMI. The PA was assessed by digital pedometer, and according to the number of steps/day, participants were classified as active (≥ 7500 steps) or sedentary (< 7500 steps). This study showed that BMI, WC, and LAP were lower in active women in both groups. In the PCOS group, total testosterone, free androgen index (FAI), and androstenedione levels were lower in active when compared to sedentary women. Besides that, a 2,000 daily step increment was an independent predictor of the FAI reduction in PCOS group. The present study showed that a more active lifestyle is associated with healthier anthropometric and metabolic profile, and may be beneficial to women with PCOS, especially for those which are obese and sedentary.
185

Suplementos alimentares: adequabilidade à legislação e efeitos metabólicos em ratos

Ferreira, Alan de Carvalho Dias 10 February 2010 (has links)
Made available in DSpace on 2015-04-17T15:03:03Z (GMT). No. of bitstreams: 1 arquivototal.pdf: 1056212 bytes, checksum: 97179266e33a5732de310daa2c8a7791 (MD5) Previous issue date: 2010-02-10 / Coordenação de Aperfeiçoamento de Pessoal de Nível Superior - CAPES / Dietary supplements are widely consumed by exercise practitioners and athletes. Researchers have noted the inadequacy of such products, as well as the presence of androgens, increasing suspicion about their true composition. The objective of this research was to list and classify food supplements sold in retail outlets in Joao Pessoa, check the products suitability to existing laws; to analyze the effects in young rats subjected to exercise, caused by the chronic ingestion of supplements widely marketed on: food intake and body weight gain, levels of total testosterone, and body composition (fat percentage and lean mass). In a survey of descriptive and experimental field, at first, we identified the products sold in Joao Pessoa city, represented by pharmacies, specialized stores and supermarkets. We compared the composition and characteristics of supplements labeled with the minimal of composition and quality set by Ordinance 222/98 ANVISA. Products that were not included in the Ordinance were classified among categories according to their composition and/or its market name. In the experimental work, sixty young male Wistar rats were distributed into five groups (n = 12/group) (TC - trained control; SC sedentary control; ST1 supplemented/trained 1; ST2 - supplemented/trained 2; ST3 - supplemented/trained 3). By gavage, ST1, ST2 and ST3 received 2.5g of each supplement and TC and SC got filtered water. Animals weight and food intake were measured weekly. After eight weeks, animals were sacrificed and blood concentration of total testosterone were measured and carcasses fat and protein determination. A total of 945 different products were determined, most of them (43%) considered Foods for Physical Activity Practitioners (FPAP) and 28% of products forbidden in Brazilian market. Among the FPAP, none of them had all the legislation features, mainly because it contains, according to the products labeling, vitamins and minerals excess, or may not show the minimum amount of protein. Considering the studied supplements, 42% showed inadequate designation and 33% showed forbidden expressions. The results of experimental work showed that both exercise and supplementation promoted less weight gain (p<0.05). The exercise did not alter the levels of total testosterone, however, the three supplements promoted reduction of testosterone levels (p <0.001). Fat percentage of ST1, ST2 and ST3 groups showed two times higher than the TC group (p<0.001). TC showed the amount of total body protein higher (p<0.05) than the supplemented groups. The high inadequacy rate, mainly with vitamins and minerals excess and the lower proportion of labeled proteins, demonstrates the need for supplements control according to the law. The suitability assessment allows to see if the supplement or group of supplements containing the nutrients minimum levels to generate their expected impact, either in performance, health or nutrition. The data indicate that chronically supplements caused an increase of adipose tissue, lower gain muscle mass and lower weight gain, mainly because of the decreased secretion of testosterone. Similar results for the three supplements tested support the hypothesis that they contain androgens or their precursors. / Suplementos alimentares têm sido extensamente consumidos por praticantes de exercícios físicos e atletas. Pesquisadores têm observado a inadequabilidade da composição destes produtos, além de detectar a presença de andrógenos, aumentando a suspeita sobre sua verdadeira composição. O objetivo dessa pesquisa foi listar e classificar os suplementos alimentares comercializados nos pontos de venda de João Pessoa; verificar a adequabilidade dos produtos à legislação vigente; analisar os efeitos em ratos jovens submetidos a exercício físico, desencadeados pela ingestão crônica de suplementos amplamente comercializados sobre: o consumo alimentar e ganho de peso corporal; níveis de testosterona total; e, composição corporal (percentual de gordura e massa magra). Em uma pesquisa de campo descritiva e experimental, em um primeiro momento, identificou-se os produtos nos pontos de venda da cidade de João Pessoa-PB, representados por farmácias, lojas especializadas e supermercados. Comparou-se a composição e as características rotuladas dos suplementos com os fatores essenciais de composição e qualidade fixadas pela Portaria 222/98 da ANVISA. Os produtos que não se enquadravam na Portaria foram classificados em categorias de acordo com sua composição e/ou sua denominação de mercado. No trabalho experimental, distribuiu-se 60 ratos machos jovens Wistar em cinco grupos (n=12/grupo) (CT controle treinado; CS controle sedentário; ST1 treinado/suplementado 1; ST2 treinado/suplementado 2; ST3 treinado/suplementado 3). Por gavagem, ST1, ST2 e ST3 receberam 2,5g de cada suplemento e CT e CS receberam água filtrada. Semanalmente, registrou-se o peso e o consumo alimentar. Após oito semanas, realizaram-se dosagens de testosterona total e determinação de gordura e proteína das carcaças. Catalogou-se 945 produtos diferentes, a maior parte (43%) considerada Alimentos para Praticantes de Atividade Física (APAF) e 28% de produtos com comercialização proibida no Brasil. Dentre os APAF, nenhum apresentou todas as características exigidas pela legislação, principalmente por conter, de acordo com o rótulo dos produtos, excesso de vitaminas e minerais, ou não apresentar a quantidade mínima de proteínas. Entre os suplementos analisados 42% apresentavam denominação inadequada e 33% apresentaram expressões proibidas. Os resultados do trabalho experimental demonstraram que tanto o exercício como a suplementação promoveram menor ganho de peso (p<0,05). O exercício não alterou os níveis de testosterona total, entretanto, os três suplementos promoveram redução destes níveis (p<0,001). Os grupos ST1, ST2, ST3 apresentaram percentual de gordura duas vezes maior do que o grupo CT (p<0,001). CT apresentou quantidade de proteína corporal total maior (p<0,05) que os suplementados. Considerando-se o alto índice de inadequabilidade, principalmente quanto ao excesso de vitaminas e minerais e à menor proporção de proteínas rotuladas, demonstra-se a necessidade de controle e fiscalização desses produtos. A avaliação da adequabilidade da composição e das características rotuladas permite verificar se o suplemento ou grupo de suplementos contém os nutrientes mínimos para gerar seus efeitos esperados, seja na performance, na saúde ou na nutrição. Os dados encontrados indicam que cronicamente os suplementos causaram aumento de tecido adiposo, menor ganho de massa muscular e menor ganho de peso, provável consequência da menor secreção de testosterona. Os resultados similares para os três grupos reforçam a hipótese de que os suplementos continham andrógenos ou seus precursores.
186

Avaliação da função endotelial em mulheres jovens portadoras da síndrome dos ovários policísticos / Avaliação da função endotelial em mulheres jovens portadoras da síndrome dos ovários policísticos / Assessment of endothelial function in young women with the polycystic ovary syndrome / Assessment of endothelial function in young women with the polycystic ovary syndrome

Viviane Christina de Oliveira 17 October 2012 (has links)
Conselho Nacional de Desenvolvimento Científico e Tecnológico / A síndrome dos ovários policísticos é uma desordem frequente e complexa, com grande variabilidade fenotípica, predominando os sinais de disfunção ovariana. Alterações metabólicas, inflamatórias e vasculares vinculadas à resistência à insulina são muito prevalentes nessa desordem podendo manifestar-se precocemente. O objetivo principal deste estudo foi investigar a presença de alterações microvasculares em mulheres jovens e não obesas portadoras da síndrome dos ovários policísticos, através de videocapilaroscopia periungueal e dosagem dos níveis séricos de endotelina-1. O objetivo secundário foi verificar a existência de associações entre os achados vasculares, níveis séricos de androgênios, parâmetros clínicos, bioquímicos, metabólicos e inflamatórios relacionados ao risco cardiovascular. Em estudo observacional, transverso e controlado avaliamos 12 mulheres com diagnóstico de síndrome dos ovários policísticos, segundo os critérios estabelecidos pelo consenso de Rotterdam e nove voluntárias saudáveis. A idade (22,82,3 X 24,62,7), o índice de massa corporal (22,53,4 X 23,73,1) e a circunferência da cintura (7510,1 X 77,38,1) foram semelhantes nos dois grupos. As portadoras da síndrome apresentavam hiperandrogenismo clínico. Não foram observadas diferenças significativas entre os grupos quando analisados os níveis séricos de estradiol, testosterona total, androstenediona ou o índice de testosterona livre, entretanto a SHBG mostrou-se significativamente mais baixa no grupo de estudo (p=0,011). A glicemia de jejum, insulina, HOMA-IR e o perfil lipídico foram normais e sem diferença entre os grupos. A amostra com síndrome dos ovários policísticos não apresentava intolerância à glicose ou Diabetes Mellitus pelo teste oral de tolerância à glicose. Os níveis séricos dos marcadores inflamatórios (leucócitos, ácido úrico, adiponectina, leptina e proteína c reativa) e do marcador de função endotelial avaliado também foram similares nos dois grupos. A velocidade de deslocamento das hemácias no basal e após oclusão foram significativamente menores nas pacientes de estudo (p=0,02), mas o tempo para atingir a VDHmax e os parâmetros relativos à morfologia e densidade capilar foram semelhantes. Não observamos correlação entre a velocidade de deslocamento das hemácias e níveis plasmáticos de endotelina-1, androgênios ou parâmetros de resistência insulínica. A velocidade de deslocamento das hemácias associou-se positivamente aos níveis plasmáticos de estradiol (r= 0,45, p<0,05) e negativamente aos de colesterol total e LDL colesterol (r= -0,52, p<0,05; r=-0,47, p<0,05, respectivamente). Em conclusão nossos resultados fornecem evidência adicional de dano precoce à função microvascular em mulheres portadoras de síndrome dos ovários policísticos. Através da capilaroscopia periungueal dinâmica, demonstramos que mulheres jovens com moderado hiperandrogenismo, sem obesidade, RI, hipertensão ou dislipidemia, já apresentam disfunção microvascular nutritiva, caracterizada por redução na velocidade de fluxo das hemácias no basal e após oclusão. Estes achados micro-circulatórios não foram acompanhados de elevações nos níveis plasmáticos de endotelina-1. / Polycystic ovary syndrome is a frequent and complex disorder, showing a great phenotypic variability, with predominance of signs of ovarian dysfunction and, more particularly, of hyperandrogenism and oligo-anovulatory cycles. This disorder shows a high prevalence of insulin resistance -related metabolic, inflammatory and vascular alterations, which may present at early stages. The main purpose of this study was to investigate the presence of microvascular alterations in young and non-obese women with polycystic ovary syndrome through periungueal videolaparoscopy and dosage of endothelin-1 serum levels. The secondary purpose was to verify further associations between vascular findings, serum androgen levels, and clinical, biochemical, metabolic and inflammatory parameters related to cardiovascular risk. We conducted an observational, transversal and controlled study to evaluate 12 women who, according to Rotterdam criteria, were diagnosed with polycystic ovary syndrome, and also nine healthy volunteers. Our selective process excluded from both groups women with smoking habits, as well as those who had made use of oral contraceptive, metformin or antilipemic drugs within three months prior to the beginning of the study. The age range (22,82,3 X 24,62,7), body mass index (22,53,4 X 23,73,1), and waist circumference (7510,1 X 77,38,1) were similar in both groups. Our patients with polycystic ovary syndrome presented clinical hyperandrogenism. Analysis of serum estradiol, total testosterone, androstenedione levels or testosterone free index disclosed no significant differences between the groups, although SHBG appeared to be expressively lower in the studied group (p=0.003). Fasting blood glucose test, insulin level, HOMA-IR and lipid profile showed normal results, and without difference between the groups. As disclosed by the oral glucose tolerance test, the group with PCOS did not present tolerance to either glucose or diabetes mellitus. When evaluated, the serum levels of inflammatory markers (leukocytes, uric acid, adinopectin, leptin and c-reactive protein) and of endothelial function marker (endothelin-1) were also similar in both groups. The red blood cell velocity at baseline and peak were significantly lower in patients with PCOS (p=0.02), although the timeframe to reach blood cell velocity at baseline and peak and the parameters referring to morphology and capillary density were similar between the groups. No association was observed between the speed of movement of red blood cells and plasma levels of endothelin-1, androgens or insulin resistance parameters. The velocity of movement of red blood cells was positively related to estradiol plasma levels (rho= 0.45, p<0.05) and negatively to the levels of total cholesterol and LDL cholesterol (rho= -0.52, p<0.05; rho=-0.47, p<0.05 respectively). Taken together, our results provide an additional evidence of early lesion to microvascular function in women with polycystic ovary syndrome. By using a simple procedure, namely the dynamic nailfoldvideocapillaroscopy, we demonstrated that young women with mild hyperandrogenism, who do not present obesity, insulin resistance, high blood pressure or dyslipidemia, already show a nutritional microvascular dysfunction, characterized by a reduced speed of red blood cells flow at basal level and after occlusion. Such microcirculatory findings were not accompanied by an increase of endothelin-1 plasma levels.
187

Marcadores de risco cardiometabólico, atividade física habitual e androgênios em mulheres com a síndrome dos ovários policísticos

Neves, Fernanda Misso Mario das January 2016 (has links)
Síndrome dos Ovários Policísticos (PCOS), caracterizada por disfunção ovulatória e hiperandrogenismo, é a endocrinopatia mais frequente entre mulheres em idade reprodutiva, afetando aproximadamente de 6 a 19% desta população, conforme o critério diagnóstico empregado. Além dos distúrbios reprodutivos, as mulheres com PCOS frequentemente apresentam maior prevalência de fatores de risco cardiometabólico como obesidade abdominal, dislipidemia, hipertensão, tolerância diminuída à glicose e diabetes mellitus tipo 2. A resistência insulínica e a hiperinsulinemia compensatória são consideradas como o ponto central destas alterações metabólicas. Os critérios atuais para diagnóstico de PCOS, a partir do Consenso de Rotterdam, indroduziram diferentes fenótipos. Os mais frequentes são o fenótipo “clássico” (hiperandrogenismo e anovulução, com ou sem a aparência policística do ovário), e o fenótipo “ovulatório” (hiperandrogenismo e aparência policística do ovário). Evidências sugerem que as mulheres com PCOS fenótipo “clássico” tenham alterações metabólicas mais severas comparadas às mulheres com o fenótipo ovulatório. Em razão disto, o objetivo do primeiro artigo original foi avaliar o desempenho da circunferência abdominal, da razão cintura-estatura, do índice de conicidade, do produto da acumulação lipídica (LAP) e do índice de adiposidade visceral (VAI) com base no modelo de homeostasia de à insulina (HOMA-IR)≥ 3,8 como padrão de referência para rastreamento de alterações Este estudo mostrou que, dentre os índices de adiposidade avaliados, os que apresentaram maior acurácia foram o LAP entre as mulheres com PCOS fenótipo “clássico” e o VAI entre as com fenótipo “ovulatório”. Aplicando o ponto de corte do LAP< 34, identificamos um subgrupo de pacientes sem alterações cardiometabólicas no grupo de mulheres com PCOS com fenótipo “clássico”, população com maior risco de hipertensão, de dislipidemia e de tolerância diminuída à glicose. Dentre as mulheres com PCOS classificadas com o fenótipo “ovulatório”, VAI≥ 1,32 foi capaz de detectar mulheres com pressão arterial significativamente mais alta e variáveis glicêmicas e lipídicas menos favoráveis em relação às mulheres com PCOS com fenótipo “ovulatório” com VAI abaixo deste ponto de corte. Atualmente, mudanças de estilo de vida (dieta e/ou exercício físico) são consideradas como primeira opção de tratamento não farmacológico nas mulheres com PCOS. Embora a prática de, pelo menos, 30 minutos por dia de exercício físico estruturado seja recomendada e tenha mostrado um potencial efeito na melhora da resistência insulínica e das variáveis antropométricas e hormonais, a manutenção deste hábito a longo prazo permanece como um ponto crítico. Neste sentido, o objetivo do segundo artigo foi avaliar o efeito da atividade física habitual (AFH) nos perfis metabólico e hormonal de mulheres com PCOS e controles pareadas por idade e índice de massa corporal (IMC). A AFH das participantes foi avaliada por meio de pedômetro digital e, conforme o número de passos diário, a participante foi classificada como ativa (≥ 7500 passos/dia) ou sedentária (< 7500 passos/dia). Mulheres ativas, em ambos os diagnósticos, apresentaram menor IMC, circunferência abdominal e LAP. No grupo PCOS, as mulheres ativas apresentaram menores valores de testosterona total, androstenediona e índice de androgênios livres (IAL) em comparação às sedentárias. Além disto, o aumento de 2000 passos foi um preditor independente de redução do IAL nas mulheres com a síndrome. Este estudo mostrou que ser mais ativa foi associado a um perfil antropométrico e metabólico mais saudável, portanto encorajar um estilo de vida mais ativo pode ser benéfico para mulheres com PCOS, especialmente para as obesas e sedentárias. / Polycystic Ovary Syndrome (PCOS) is characterized by ovulatory dysfunction a hyperandrogenism. The prevalence of PCOS in women of reproductive age range from 6- 19%. Women with PCOS present higher prevalence of cardiometabolic risk factors as abdominal obesity, dyslipidemia, hypertension, impaired glucose tolerance and diabetes mellitus type 2. These metabolic abnormalities have been primarily linked to insulin resistance. Currently, the diagnosis of PCOS is confirmed according the Rotterdam Consensus. The more frequent phenotypes are the classic phenotype (hyperandrogenism and anovulation with or without polycystic ovary appearance), and the ovulatory phenotype (hyperandrogenism and polycystic ovary appearance). Evidence suggests that women with classic PCOS phenotype present more severe metabolic alterations compared to women with ovulatory PCOS phenotype. The aim of the first study was to evaluate the performance of the waist circumference (WC), waist-to-height ratio, conicity index, lipid accumulation product (LAP), and visceral adiposity index (VAI) based on homeostasis model assessment of insulin resistance (HOMA- IR)≥ 3.8 as standard reference for screening preclinical metabolic alterations and cardiovascular risk factors in classic PCOS and ovulatory PCOS phenotypes. Among these indexes, LAP had the best accuracy for screening metabolic alterations in classic PCOS phenotype, while VAI had the best accuracy for ovulatory PCOS phenotype. cardiometabolic alterations in the group with classic PCOS, a phenotype which is characterized by higher risk for hypertension, dyslipidemia, and impaired glucose tolerance. In ovulatory PCOS, VAI≥ 1.32 was useful to detect women with significantly higher blood pressure and less favorable glycemic and lipid variables as compared to ovulatory PCOS with lower VAI. In addition, lifestyle intervention (diet and/or exercise) is the first-line treatment for PCOS. Although structured exercise (at least 30 minutes daily) has been recommended and has shown a potential effect on improving insulin resistance, anthropometric, and hormonal variables, the long-term maintenance of exercise remains a critical point. Therefore, the aim of the second study was to objectively examine the effect of habitual PA on metabolic, hormonal, BMI, and anthropometric variables of women with PCOS and a control group, matched by age and BMI. The PA was assessed by digital pedometer, and according to the number of steps/day, participants were classified as active (≥ 7500 steps) or sedentary (< 7500 steps). This study showed that BMI, WC, and LAP were lower in active women in both groups. In the PCOS group, total testosterone, free androgen index (FAI), and androstenedione levels were lower in active when compared to sedentary women. Besides that, a 2,000 daily step increment was an independent predictor of the FAI reduction in PCOS group. The present study showed that a more active lifestyle is associated with healthier anthropometric and metabolic profile, and may be beneficial to women with PCOS, especially for those which are obese and sedentary.
188

Etudes des mécanismes à l'origine de l'excès de garçons dans la déficience intellectuelle et les troubles du spectre autistique / Mechanisms involved in the male excess observed in intellectual disability and autism spectrum disorders

Quartier, Angelique 13 January 2017 (has links)
La déficience intellectuelle (DI) et les troubles du spectre autistique (ASD) sont deux troubles neurodéveloppementaux (NDD) présentant de nombreux chevauchements génétiques et phénotypiques ainsi qu’un biais de sexe important, avec plus de garçons atteints (1,4x plus pour la DI et 4x plus pour l'ASD). Au sein de notre laboratoire, le taux de diagnostic des patients souffrant de DI et/ou d’ASD est significativement plus élevé chez les filles que chez les garçons. De façon surprenante, nous n’avons pas observé de différence significative entre filles et garçons au niveau de la proportion de mutations pathogènes sur le chromosome X (5,3% versus 7,6%), confirmant ainsi que les mutations causales totalement pénétrantes sur ce chromosome ne peuvent pas expliquer la totalité de l’excès de garçons atteints de DI ou d'ASD. Nous avons donc choisi d’étudier une autre des hypothèses, plus environnementale, qui pourrait rendre le cerveau masculin plus susceptible au développement de NDD : le rôle des androgènes au cours du développement du cerveau. J'ai étudié l’effet de ces hormones masculines dans des précurseurs neuronaux humains (hNSCs) et observé que les androgènes augmentent la prolifération des hNSCs et les protègent contre la mort cellulaire en conditions stressantes. J'ai également mis en évidence que les androgènes, via leur récepteur (le récepteur aux androgènes), régulent une centaine de gènes dans les hNSCs avec, parmi eux, un enrichissement en gènes connus pour être différentiellement exprimés chez les individus avec ASD (dont NRCAM et FAM107A). La régulation de ces gènes par les androgènes pendant le développement du cerveau pourrait ainsi participer à la sensibilité accrue du cerveau masculin, exposé à d'autres facteurs génétiques et environnementaux, à développer une NDD. / Intellectual disability (ID) and autism spectrum disorders (ASD) are two common neurodevelopmental disorders (NDD) with many genetic and phenotypic overlaps. Another common feature is the existence of a gender bias, very strong for ASD (4 males for 1 female) and notable for ID (1.4:1). In our team, the diagnostic yield of patients affected by ID with or wihout ASD is significantly higher in girls than in boys. Surprisingly, we did not observe a significant difference between girls and boys in the proportion of pathogenic mutations on the X chromosome (5.3% versus 7.6%), confirming that rare and fully penetrant mutations on this chromosome can not explain the totality this male bias observed in ID and ASD. We have therefore chosen to study another hypothesis, more environmental, which could make the male brain more susceptible to develop NDD: the role of androgens during brain development. I studied the effect of these male hormones in human neuronal precursors (hNSCs) and observed that androgens increase the proliferation of hNSCs and protect them against cell death under stressful conditions. I also showed that androgens, via their receptor (the androgen receptor), regulate a hundred genes in hNSCs with, among them, an enrichment of genes known to be differentially expressed in individuals with ASD (e.g NRCAM and FAM107A). The regulation of these genes by androgens during brain development could thus contribute to the increased sensitivity of the male brain, exposed to other genetic and environmental factors, to develop an NDD.
189

Régulation des fonctions musculaires par les glucocorticoïdes et les androgènes / Regulation of muscular functions by glucocorticoids and androgens

Ueberschlag-Pitiot, Vanessa 13 September 2016 (has links)
L’utilisation de glucocorticoïdes (GC) pour le traitement de maladies inflammatoires ou d’antagonistes des androgènes pour le cancer de la prostate est limitée par l’induction d’effets secondaires, tels que l’atrophie musculaire. Comme les mécanismes sous-jacents étaient mal connus, nous avons caractérisé le rôle de ces hormones dans la régulation des fonctions musculaires. Nos résultats montrent que le récepteur aux GC des myofibres contrôle négativement la masse musculaire par des actions distinctes en présence de concentrations physiologiques et pharmacologiques de GC. De plus, notre étude a permis d’identifier de nouveaux réseaux de gènes contrôlés par les GC dans le muscle. Nous avons également démontré que les androgènes favorisent le gain de performance musculaire via l’amélioration de la force. Ainsi, cette étude a clarifié les mécanismes régulant l’homéostasie musculaire et ouvre des perspectives prometteuses pour identifier de nouvelles cibles thérapeutiques. / The use of glucocorticoids (GC) to treat inflammatory diseases or androgen antagonists for prostate cancer is limited by the occurrence of side effects such as muscle atrophy. As the underlying mechanisms were unclear, we characterized the effects of GC and androgens on muscle mass and function. Our results demonstrate that myofiber GC receptor negatively controls muscle mass by distinct actions under physiological and pharmacological levels of GC. Moreover, our data identified many genes and networks controlled by GC in myofibers. We also showed that androgens promote the gain in muscle performance during postnatal development via the improvement of specific maximal force and power. Thus, this study allowed to clarify the molecular and cellular mechanisms regulating muscle homeostasis, and paves the way to identify new therapeutic targets.
190

Hyperandrogenism, menstrual irregularities and polycystic ovary syndrome:impact on female reproductive and metabolic health from early adulthood until menopause

Pinola, P. (Pekka) 30 August 2016 (has links)
Abstract Polycystic ovary syndrome (PCOS) is the most common endocrine disorder of women of reproductive age, affecting 5–18% of them. Menstrual irregularities, hyperandrogenemia and obesity are key features in PCOS and they are suggested to be the most important metabolic risks linked to PCOS, but their respective roles are still under debate. Anti-Müllerian hormone (AMH) is involved in sexual differentiation and follicle growth and its level is increased in women with PCOS. The aims of this project were to clarify the significance of menstrual irregularities, hyperandrogenemia and serum levels of AMH in adolescence as predictive factors of the syndrome and to investigate the respective roles of obesity and hyperandrogenism as metabolic risk factors in women with PCOS from adolescence to late adulthood. The study populations were the Northern Finland Birth Cohort 1986 (N=3373 women) and a Nordic population including 1553 women with PCOS and 448 controls. At the age of 16 years, women with menstrual irregularities were more hyperandrogenic compared with women with normal menstrual cycles. Serum AMH levels correlated positively with those of testosterone at this age. They were higher in adolescents with menstrual irregularities compared with those with regular cycles and in women with hirsutism or PCOS at the age of 26 years. However, AMH was not a good marker of metabolic abnormalities in adolescence or a reliable tool to predict PCOS in later life. Androgen levels were higher in women with PCOS throughout life compared with controls. The parameters that best predicted PCOS at all ages were the free androgen index, and androstenedione. Women with PCOS exhibited increased abdominal obesity, altered insulin metabolism, worse lipid profiles and higher blood pressure from early adulthood until menopause compared with controls. The highest prevalence of metabolic syndrome was detected in obese and hyperandrogenic women with PCOS. In conclusion, irregular menstrual cycles, identified by a simple question at adolescence, represent a good marker of hyperandrogenemia, later metabolic risks and development of PCOS. Due to the persistence of hyperandrogenism and metabolic alterations, the treatment of PCOS should be focused on prevention and treatment of these problems as early as in adolescence in order to decrease future morbidity. / Tiivistelmä Monirakkulainen munasarjaoireyhtymä (polycystic ovary syndrome, PCOS) on lisääntymisikäisten naisten tavallisin (5-18%) hormonaalinen häiriö. Kuukautishäiriöt, mieshormoniylimäärä eli hyperandrogenismi ja lihavuus kuuluvat oireyhtymään oleellisesti ja niiden ajatellaan olevan tärkeimmät PCOS:aan liittyvät metaboliset riskitekijät, vaikkakin niiden tarkat roolit ovat epäselvät. Anti-Müllerian hormoni (AMH) vaikuttaa sukupuolen kehitykseen sikiöaikana sekä munarakkuloiden kypsymiseen hedelmällisessä iässä ja sen pitoisuus on suurentunut PCOS-naisilla. Tämän väitöskirjan tavoitteena oli selvittää kuukautishäiriöiden, hyperandrogenismin ja AMH-pitoisuuden ennustearvoa PCOS-oireyhtymälle, sekä arvioida lihavuuden ja hyperandrogenismin vaikutusta metabolisiin riskitekijöihin PCOS-naisilla läpi elämän. Tutkimusaineistoina olivat Pohjois-Suomen syntymäkohortti 1986 (N=3373 naista) sekä pohjoismaalainen yhteistyöaineisto, jossa oli 1553 PCOS-naista ja 448 kontrollia. 16-vuotiaiden kuukautishäiriöistä kärsivien naisten mieshormonipitoisuuksien todettiin olevan korkeammat kuin naisilla, joilla kuukautiskierto oli säännöllinen. AMH-tasot korreloituivat positiivisesti testosteronin kanssa 16-vuotiaana, ja pitoisuus oli koholla naisilla, joilla todettiin kuukautishäiriö. AMH-tasot 16-vuotiaana olivat myös korkeampia naisilla, joilla oli 26-vuotiaana PCOS tai hirsutismi. Kuitenkaan AMH-pitoisuus 16-vuotiaana ei korreloinut metabolisten riskitekijöiden kanssa eikä se ollut luotettava parametri ennustamaan PCOS:n kehittymistä. Mieshormonitasot olivat korkeammat PCOS-naisilla läpi elämän verrattuna kontrolleihin. Vapaan mieshormonin indeksit ja androstendioni olivat parhaat parametrit erottamaan PCOS-naiset kontrolleista. PCOS-naisilla todettiin olevan enemmän vyötärölihavuutta, huonompi veren rasvaprofiili ja korkeampi verenpaine varhaisaikuisuudesta menopaussiin saakka. Lihavilla hyperandrogeenisilla naisilla todettiin suurin metabolisen oireyhtymän esiintyvyys. Yksinkertaisella kysymyksellä selvitetyt kuukautishäiriöt nuoruusiässä todettiin olevan yhteydessä hyperandrogenismiin sekä myöhempiin metabolisiin riskeihin ja PCOS:n kehittymiseen. Jotta pystyttäisiin vähentämään myöhempää sairastavuutta ja kuolleisuutta PCOS-naisilla, oireyhtymän hoidon tulisi keskittyä ennaltaehkäisemään ja hoitamaan lihavuutta, hyperandrogenismia ja metabolisia riskejä jo varhaisaikuisuudessa.

Page generated in 0.0879 seconds